Events
WCLC 2022: National Lung Screening trial finds second primary lung cancer is 4 percent and as high as 8 percent among surgery patients
- WCLC 2022: NELSON trial protocol more sensitive than National Lung Screening trial and may increase the benefits of lung cancer screening
- WCLC 2022: Study of lung cancer gene panel testing demonstrates cytological specimens accurate
- WCLC 2022: IASLC Early Detection and Screening Committee report on global obstacles to lung cancer screening in low-to middle-income countries
Cancer care needs mass COVID-19 testing
Thousands of cancer patients in the UK have had their treatment stopped or delayed because of COVID-19, and with pressures…










